Clinical Trial Update: Benfotiamine in Diabetic Nephropathy [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 trial evaluating benfotiamine for diabetic nephropathy at the University Medical Center Groningen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Benfotiamine (benfotiamine)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Diabetic Nephropathy | Phase 4 | Status: COMPLETED